Sign up
Pharma Capital
EPIC: SHP
Market: LSE
52-week High/Low: 5,067.00p / 3,435.50p
Sector: Pharma & Biotech
Market Cap: 34,137.57M
Website: www.shire.com

Shire Plc is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases.

 

Shire Plc

www.shire.com

Interactive graph

col 3
col 4
col 5
col 6

Shire Plc Timeline

View All

Columns Including SHP

VIEW ALL

Market Reports Including SHP

VIEW ALL

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.